PATENT CLAIM ANALYSIS

Application Number: 15761301
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "019300"]

Abstract:
Disclosed herein are immunogenic glycopeptide compounds for inducing immune responses to prevent and/or treat cancer. Other aspects of the present disclosure are pharmaceutical compositions comprising the immunogenic glycopeptide compounds, and methods using the compounds for preventing and/or treating a cancer in a subject.

Claim (Index 10):
A pharmaceutical composition comprising a therapeutically effective amount of an immunogenic glycopeptide compound of any one of  claims 1  to  9 , and a pharmaceutically acceptable carrier or adjuvant.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 90.0
- Lexical Diversity: 1.35294
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12537129', '15126945', '15655105', '10209618', '14675838']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7991767143990899
- 35 USC 102 Novelty (BERT): 0.5422215948932517
- Combined Prediction Score: 0.773481202448506
- Mean Citation Score: 406.025268
- Max Citation Score: 409.99753
- Similarity Product: 283.8065484041482

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test